The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: November 2022

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research. Previously known as our Top 10 Cancer Research Publications, it is curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

7. The metastatic spread of breast cancer accelerates during sleep

  • 1. H3K27me3 conditions chemotolerance in triple-negative breast cancer
  • 2. Spatially resolved clonal copy number alterations in benign and malignant tissue
  • 3. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis
  • 4. Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy
  • 5. Genome-wide mapping of somatic mutation rates uncovers drivers of cancer
  • 6. Protein phosphatase 2A inactivation induces microsatellite instability, neoantigen production and immune response
  • 7. The metastatic spread of breast cancer accelerates during sleep
  • 8. Genome-wide identification and analysis of prognostic features in human cancers
  • 9. A pan-cancer compendium of chromosomal instability
  • 10. Structure of the MRAS-SHOC2-PP1C phosphatase complex
Previous
Next

Diamantopoulou, Z., Castro-Giner, F., Schwab, F.D. et al. Nature 607, 156–162 (2022).
doi: 10.1038/s41586-022-04875-y.

Summary of findings

Distant metastasis is achieved by the hematogenous dissemination of circulating tumor cells (CTCs). However, the temporal dynamics that dictate the generation of metastasis-competent CTCs have been often neglected, assuming that CTCs are constantly shed from growing tumors or shed as a consequence of mechanical insults. We observe a striking and unexpected pattern of CTC generation dynamics in both patients with breast cancer and mouse models, highlighting that the vast majority of spontaneous CTC intravasation events occur during sleep. We demonstrate that rest-phase CTCs are highly metastasis-prone compared to CTCs that are generated during the active phase. Mechanistically, single cell-resolution RNA sequencing analysis of CTCs reveals a dramatic upregulation of mitotic genes during the rest phase in both patients and mouse models, enabling metastasis proficiency. At the systemic level, we find that key circadian rhythm hormones such as melatonin, testosterone and glucocorticoids dictate CTC generation dynamics, and as a consequence, that insulin directly promotes tumor cell proliferation in vivo, yet in a time-dependent manner. Thus, the spontaneous generation of CTCs with a high metastatic ability does not occur continuously, but it is concentrated within the rest phase of the host, providing a new rationale for time-controlled interrogation and treatment of metastasis-prone cancers.

Graphical representation of the human circadian rhythm. The white and black bars represent environmental light (active period) and dark conditions (rest period), respectively (left). The radial histograms show the percent of single CTCs, CTC clusters and CTC-WBC clusters isolated during the rest or active phase in early- or late-stage breast cancer patients. n=21 early-stage and n=9 late-stage patients. The vast majority of CTCs are detected during the rest phase.

Read more in Nature 

 

7. The metastatic spread of breast cancer accelerates during sleep

  • 1. H3K27me3 conditions chemotolerance in triple-negative breast cancer
  • 2. Spatially resolved clonal copy number alterations in benign and malignant tissue
  • 3. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis
  • 4. Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy
  • 5. Genome-wide mapping of somatic mutation rates uncovers drivers of cancer
  • 6. Protein phosphatase 2A inactivation induces microsatellite instability, neoantigen production and immune response
  • 7. The metastatic spread of breast cancer accelerates during sleep
  • 8. Genome-wide identification and analysis of prognostic features in human cancers
  • 9. A pan-cancer compendium of chromosomal instability
  • 10. Structure of the MRAS-SHOC2-PP1C phosphatase complex
Previous
Next
Tags: EACR Top Ten Cancer Research Publications

Related Posts

Highlights in Cancer Research: November 2022

Highlights in Cancer Research: April 2026

April 28, 2026

The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of...

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

April 20, 2026

The EACR, AACR, and The Mark Foundation for Cancer Research recently teamed up to offer a number of travel grants to help EACR or AACR members...

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

April 22, 2026

https://www.youtube.com/watch?v=KdMqmIIgNYo Click above to watch On 9 April 2026, the EACR hosted a free webinar bringing together leading experts to explore the Cancer Genome Interpreter (CGI)...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

EACR Travel Grant recipients at The Tumour Ecosystem 2026
Community

EACR Travel Grant recipients at The Tumour Ecosystem 2026

May 5, 2026
VIDEO | ctDNA-Guided Risk Stratification and Surveillance in Colorectal Cancer
News

VIDEO | ctDNA-Guided Risk Stratification and Surveillance in Colorectal Cancer

May 1, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR